Enzolytics Operating Margin vs. Cash Flow From Operations
Based on Enzolytics' profitability indicators, Enzolytics may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in December. Profitability indicators assess Enzolytics' ability to earn profits and add value for shareholders.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Please note, there is a significant difference between Enzolytics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Enzolytics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enzolytics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
For Enzolytics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Enzolytics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Enzolytics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Enzolytics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Enzolytics over time as well as its relative position and ranking within its peers.
Enzolytics |
Enzolytics Cash Flow From Operations vs. Operating Margin Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Enzolytics's current stock value. Our valuation model uses many indicators to compare Enzolytics value to that of its competitors to determine the firm's financial worth. Enzolytics is rated # 4 in operating margin category among its peers. It is one of the top stocks in cash flow from operations category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Enzolytics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Enzolytics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Enzolytics Cash Flow From Operations vs. Operating Margin
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Enzolytics |
| = | (19.24) % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Enzolytics |
| = | 4.89 M |
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
Enzolytics Cash Flow From Operations Comparison
Enzolytics is currently under evaluation in cash flow from operations category among its peers.
Enzolytics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Enzolytics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Enzolytics will eventually generate negative long term returns. The profitability progress is the general direction of Enzolytics' change in net profit over the period of time. It can combine multiple indicators of Enzolytics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Enzolytics, Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. In addition, it has created a proprietary cell line that produces human monoclonal antibodies that target and neutralizes the HIV virus. Enzolytics operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Enzolytics Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Enzolytics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Enzolytics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Enzolytics' important profitability drivers and their relationship over time.
Use Enzolytics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Enzolytics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enzolytics will appreciate offsetting losses from the drop in the long position's value.Enzolytics Pair Trading
Enzolytics Pair Trading Analysis
The ability to find closely correlated positions to Enzolytics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Enzolytics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Enzolytics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Enzolytics to buy it.
The correlation of Enzolytics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Enzolytics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Enzolytics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Enzolytics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Enzolytics position
In addition to having Enzolytics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Mid Cap ETFs Thematic Idea Now
Mid Cap ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Mid Cap ETFs theme has 70 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Mid Cap ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Enzolytics Pink Sheet
To fully project Enzolytics' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Enzolytics at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Enzolytics' income statement, its balance sheet, and the statement of cash flows.